Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Loop Genomics

Loop Genomics
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$9.2M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of a long-read DNA sequencing technology designed to transforms any short read sequencer into a single molecule long read sequencer. The company's technology encompasses consumables and analysis tools that are intended to address a wide range of genetic analysis solutions for research, diagnostics, agbio and industrial applications, enabling clients with accurate, long-read sequencing and single molecule counting using a lab's existing sequencing hardware.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 5941 Optical Court
  • San Jose, CA 95138
  • United States

+1 (408) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Loop Genomics’s full profile, request a free trial.

Loop Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 14-Feb-2018 $9.2M 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 00.000 Completed Startup
2. Early Stage VC 20-May-2016 $1.5M $1.62M Completed Startup
1. Accelerator/Incubator 23-Mar-2016 $120K $120K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Loop Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A-4 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-3 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A-1 1,214,181 $0.000010 $0.03 $0.41 $0.41 1x $0.41 5.21%
Series A 6,861,063 $0.000010 $0.09 $1.17 $1.17 1x $1.17 24.88%
To view this company’s complete Cap Table, request access »

Loop Genomics Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
10x Genomics Venture Capital-Backed Pleasanton, CA 000 00000 0000000000 0 00000
000000 Formerly VC-backed Providence, RI 00 000.00 0000
0000 0000000 Corporate Backed or Acquired Constance, Germany 000 000000&0
00000 Corporation Woburn, MA 00 000 00000000 000
0000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Loop Genomics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
DN Capital Venture Capital Minority 000 0000 000000 0
Fusion Fund Venture Capital Minority 000 0000 000000 0
Rising Tide Fund Venture Capital Minority 000 0000 000000 0
Wisemont Capital Venture Capital Minority 000 0000 000000 0
11.2 Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Loop Genomics Executive Team (2)

Name Title Board
Seat
Contact
Info
Tuval Ben-Yehezkel Ph.D Founder, Board Member, President & Chief Executive Officer
Tony Lialin Chief Commercial Officer